• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利决策过程中健康经济评估的现状。

The status of health economic evaluation within decision making in Austria.

作者信息

Zechmeister-Koss Ingrid, Stanak Michal, Wolf Sarah

机构信息

Ludwig Boltzmann Institute for Health Technology Assessment, Garnisongasse 7/20, 1090, Vienna, Austria.

Department of Philosophy, University of Vienna, Vienna, Austria.

出版信息

Wien Med Wochenschr. 2019 Sep;169(11-12):271-283. doi: 10.1007/s10354-019-0689-8. Epub 2019 Mar 12.

DOI:10.1007/s10354-019-0689-8
PMID:30868427
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6713695/
Abstract

BACKGROUND

Given limited resources compared to the demand for them, spending resources efficiently is important. Key methods applied for supporting efficient resource allocation are health economic evaluations.

METHODS

Based on secondary literature, we analyze international challenges for using two types of economic evaluations-cost-effectiveness analysis and cost-utility analysis-in reimbursement decisions and reflect on them for the Austrian case.

RESULTS

The main challenges with the application of economic evaluations are related to the methods, the decision-making culture, and the respective system. The challenges also apply to the Austrian Bismarck system, where almost no formal requirements for using economic evaluations exist, except on a case-by-case basis. Resource allocation in Austria hence occurs, for the most part, implicitly.

CONCLUSION

One way forward towards more explicit efficiency considerations may be to consider more descriptive study types and foster capacity building, standardization of methods and presentation of results, and a mandatory detailed guideline.

摘要

背景

鉴于资源有限而需求无限,有效利用资源至关重要。用于支持高效资源分配的关键方法是卫生经济评估。

方法

基于二手文献,我们分析了在报销决策中使用两种经济评估方法(成本效益分析和成本效用分析)所面临的国际挑战,并针对奥地利的情况进行了思考。

结果

经济评估应用的主要挑战与方法、决策文化和各自的体系有关。这些挑战也适用于奥地利的俾斯麦体系,在该体系中,除了个别情况外,几乎没有使用经济评估的正式要求。因此,奥地利的资源分配在很大程度上是隐性的。

结论

朝着更明确的效率考量方向前进的一种方法可能是考虑更多描述性研究类型,并促进能力建设、方法标准化和结果呈现,以及制定强制性的详细指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f3/6713695/3930568db3d2/10354_2019_689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f3/6713695/5e2cbeae1365/10354_2019_689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f3/6713695/3930568db3d2/10354_2019_689_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f3/6713695/5e2cbeae1365/10354_2019_689_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f3/6713695/3930568db3d2/10354_2019_689_Fig2_HTML.jpg

相似文献

1
The status of health economic evaluation within decision making in Austria.奥地利决策过程中健康经济评估的现状。
Wien Med Wochenschr. 2019 Sep;169(11-12):271-283. doi: 10.1007/s10354-019-0689-8. Epub 2019 Mar 12.
2
[Economic evaluation in health care].[医疗保健中的经济评估]
Wien Med Wochenschr. 2009;159(5-6):160-8. doi: 10.1007/s10354-008-0548-5.
3
[Health economics studies in dermatology].[皮肤病学中的卫生经济学研究]
Hautarzt. 2006 Apr;57(4):297-302. doi: 10.1007/s00105-005-0982-x.
4
Costing evidence for health care decision-making in Austria: A systematic review.奥地利医疗保健决策的成本核算证据:一项系统综述。
PLoS One. 2017 Aug 14;12(8):e0183116. doi: 10.1371/journal.pone.0183116. eCollection 2017.
5
[Theoretical implications of health economic evaluations in an Austrian context].[奥地利背景下卫生经济评估的理论意义]
Wien Med Wochenschr. 2006 Dec;156(23-24):622-7. doi: 10.1007/s10354-006-0359-5.
6
Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?卫生经济评估中的单位成本:奥地利将走向何方?
Int J Environ Res Public Health. 2022 Dec 22;20(1):117. doi: 10.3390/ijerph20010117.
7
The impact of health economic evaluations in Sweden.健康经济评估在瑞典的影响。
Z Evid Fortbild Qual Gesundhwes. 2014;108(7):375-82. doi: 10.1016/j.zefq.2014.09.006. Epub 2014 Sep 23.
8
International standards for health economic evaluation with a focus on the German approach.国际卫生经济评估标准,重点介绍德国方法。
J Clin Pharm Ther. 2013 Aug;38(4):277-85. doi: 10.1111/jcpt.12043. Epub 2013 Apr 26.
9
[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].[药物经济学分析与奥地利药品定价及报销决策的相关性]
Wien Med Wochenschr. 2006 Dec;156(23-24):612-8. doi: 10.1007/s10354-006-0357-7.
10
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.

引用本文的文献

1
The role of health economics within health technology assessment: past, present, and future - an Austrian perspective.卫生经济学在卫生技术评估中的作用:过去、现在和未来——奥地利视角。
Int J Technol Assess Health Care. 2024 Nov 5;40(1):e51. doi: 10.1017/S0266462324000503.
2
Assessing social protection influence on health status in the European Union.评估社会保护对欧盟健康状况的影响。
Front Public Health. 2024 Mar 11;12:1287608. doi: 10.3389/fpubh.2024.1287608. eCollection 2024.
3
Rationing in healthcare-a scoping review.医疗保健中的配给制:范围综述。

本文引用的文献

1
Pre-reimbursement: early assessment for coverage decisions.报销前:进行覆盖范围决策的早期评估。
Wien Med Wochenschr. 2019 Sep;169(11-12):254-262. doi: 10.1007/s10354-019-0683-1. Epub 2019 Feb 6.
2
Most important barriers and facilitators of HTA usage in decision-making in Europe.欧洲卫生技术评估(HTA)在决策过程中最重要的障碍和促进因素。
Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):297-304. doi: 10.1080/14737167.2018.1421459. Epub 2018 Jan 5.
3
Does the approach to economic evaluation in health care depend on culture, values, and institutional context?
Front Public Health. 2023 Jun 21;11:1160691. doi: 10.3389/fpubh.2023.1160691. eCollection 2023.
4
Unit Costs in Health Economic Evaluations: Quo Vadis, Austria?卫生经济评估中的单位成本:奥地利将走向何方?
Int J Environ Res Public Health. 2022 Dec 22;20(1):117. doi: 10.3390/ijerph20010117.
5
A novel set of Austrian reference unit costs for comprehensive societal perspectives consistent with latest European costing methods for economic evaluations.一套新颖的奥地利参考单位成本,用于全面的社会视角,符合最新的欧洲成本效益分析方法。
Wien Klin Wochenschr. 2024 Jan;136(1-2):1-12. doi: 10.1007/s00508-022-02128-6. Epub 2022 Dec 23.
6
Harmonization issues in unit costing of service use for multi-country, multi-sectoral health economic evaluations: a scoping review.多国家、多部门卫生经济评估中服务使用单位成本核算的协调问题:一项范围综述
Health Econ Rev. 2022 Aug 3;12(1):42. doi: 10.1186/s13561-022-00390-y.
7
"Slow science" for 21st century healthcare: reinventing health service research that serves fast-paced, high-complexity care organisations."慢科学"在 21 世纪医疗保健中的应用:重新构想服务于快节奏、高复杂性医疗保健组织的卫生服务研究。
J Health Organ Manag. 2021 May 4;ahead-of-print(ahead-of-print):701-16. doi: 10.1108/JHOM-06-2020-0218.
8
Barriers and facilitators to conducting economic evaluation studies of Gulf Cooperation Council (GCC) countries: a survey of researchers.海湾合作委员会(GCC)国家开展经济评估研究的障碍与促进因素:一项对研究人员的调查
Health Res Policy Syst. 2021 May 1;19(1):71. doi: 10.1186/s12961-021-00721-1.
9
Embedding an economist in regional and rural health services to add value and reduce waste by improving local-level decision-making: protocol for the 'embedded Economist' program and evaluation.将一名经济学家融入地区和农村卫生服务机构,通过改善地方层面的决策来增加价值并减少浪费:“嵌入式经济学家”项目及评估方案
BMC Health Serv Res. 2021 Mar 6;21(1):201. doi: 10.1186/s12913-021-06181-1.
医疗保健中的经济评估方法是否取决于文化、价值观和制度背景?
Eur J Health Econ. 2018 Jul;19(6):769-774. doi: 10.1007/s10198-017-0943-1.
4
Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.运用最佳-最差标度法评估奥地利卫生技术评估使用过程中最重要的障碍因素和促进因素。
Expert Rev Pharmacoecon Outcomes Res. 2018 Apr;18(2):223-232. doi: 10.1080/14737167.2017.1375407. Epub 2017 Sep 8.
5
Costing evidence for health care decision-making in Austria: A systematic review.奥地利医疗保健决策的成本核算证据:一项系统综述。
PLoS One. 2017 Aug 14;12(8):e0183116. doi: 10.1371/journal.pone.0183116. eCollection 2017.
6
Netherlands: Health System Review.荷兰:卫生系统综述。
Health Syst Transit. 2016 Mar;18(2):1-240.
7
Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008-2015.影响医疗器械覆盖决策的因素:对2008 - 2015年奥地利医院福利目录中78项医疗器械评估的回顾性分析
Health Policy. 2016 Aug;120(8):903-12. doi: 10.1016/j.healthpol.2016.06.007. Epub 2016 Jun 16.
8
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.英国国家卫生与临床优化研究所成本效益阈值的估计方法。
Health Technol Assess. 2015 Feb;19(14):1-503, v-vi. doi: 10.3310/hta19140.
9
The impact of health economic evaluations in Sweden.健康经济评估在瑞典的影响。
Z Evid Fortbild Qual Gesundhwes. 2014;108(7):375-82. doi: 10.1016/j.zefq.2014.09.006. Epub 2014 Sep 23.
10
Twenty years of using economic evaluations for drug reimbursement decisions: what has been achieved?20 年药物报销决策中的经济评价应用:取得了哪些成果?
J Health Polit Policy Law. 2013 Dec;38(6):1081-102. doi: 10.1215/03616878-2373148. Epub 2013 Aug 23.